Cornerstone Capital Management Holdings’s Halozyme HALO Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.07M	Sell	53,063 -5,300	-9%	-$97.4K	0.01%	885
2017 Q3	$1.01M	Buy	58,363 +400	+0.7%	+$5.42K	0.01%	926
2017 Q2	$742K	Buy	57,963 +396	+0.7%	+$5.29K	0.01%	973
2017 Q1	$745K	Buy	57,567 +51,814	+901%	+$655K	0.01%	982
2016 Q4	$56K	Sell	5,753 -13,400	-70%	-$147K	﹤0.01%	1272
2016 Q3	$231K	Sell	19,153 -1,532	-7%	-$15.7K	﹤0.01%	1178
2016 Q2	$179K	Buy	20,685 +18,900	+1,059%	+$187K	﹤0.01%	1208
2016 Q1	$17K	Sell	1,785 -12,037	-87%	-$113K	﹤0.01%	1448
2015 Q4	$240K	Sell	13,822 -16,978	-55%	-$271K	﹤0.01%	1182
2015 Q3	$413K	Sell	30,800 -69,300	-69%	-$1.39M	﹤0.01%	1064
2015 Q2	$2.26M	Buy	100,100 +92,300	+1,183%	+$1.62M	0.02%	673
2015 Q1	$111K	Buy	+7,800	New	+$112K	﹤0.01%	1259
2014 Q4	–	Sell	-800	Closed	-$7K	–	1288
2014 Q3	$7K	Buy	+800	New	+$7.62K	﹤0.01%	1251
2014 Q2	–	Sell	-27,900	Closed	-$354K	–	1340
2014 Q1	$354K	Buy	+27,900	New	+$414K	﹤0.01%	1033

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cornerstone Capital Management Holdings's HALO Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Halozyme (HALO) stake by 9.1% in Q4 2017, selling an estimated $97.4K and leaving 53,063 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #885.

Cornerstone Capital Management Holdings first reported a position in HALO in Q1 2014 and has held it in 14 quarters since. The position peaked at $2.26M in Q2 2015. 198 funds tracked by Wall St. Rank hold HALO as of Q4 2017.

Cornerstone Capital Management Holdings held 53,063 shares of Halozyme worth $1.07M as of Q4 2017.
Cornerstone Capital Management Holdings sold 5,300 Halozyme shares in Q4 2017, an estimated $97.4K.
Halozyme made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #885 holding.
Cornerstone Capital Management Holdings first reported a position in Halozyme in Q1 2014 and has held it in 14 quarters since.
Cornerstone Capital Management Holdings's Halozyme position peaked at $2.26M in Q2 2015.
198 funds tracked by Wall St. Rank held Halozyme as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.